Skip to main content
Top
Published in: BMC Infectious Diseases 1/2010

Open Access 01-12-2010 | Research article

Comparison of commercial DNA preparation kits for the detection of Brucellae in tissue using quantitative real-time PCR

Authors: Herbert Tomaso, Mireille Kattar, Meike Eickhoff, Ulrich Wernery, Sascha Al Dahouk, Eberhard Straube, Heinrich Neubauer, Holger C Scholz

Published in: BMC Infectious Diseases | Issue 1/2010

Login to get access

Abstract

Background

The detection of Brucellae in tissue specimens using PCR assays is difficult because the amount of bacteria is usually low. Therefore, optimised DNA extraction methods are critical. The aim of this study was to assess the performance of commercial kits for the extraction of Brucella DNA.

Methods

Five kits were evaluated using clinical specimens: QIAamp™ DNA Mini Kit (QIAGEN), peqGold™ Tissue DNA Mini Kit (PeqLab), UltraClean™ Tissue and Cells DNA Isolation Kit (MoBio), DNA Isolation Kit for Cells and Tissues (Roche), and NucleoSpin™ Tissue (Macherey-Nagel). DNA yield was determined using a quantitative real-time PCR assay targeting IS711 that included an internal amplification control.

Results

Kits of QIAGEN and Roche provided the highest amount of DNA, Macherey-Nagel and Peqlab products were intermediate whereas MoBio yielded the lowest amount of DNA. Differences were significant (p < 0.05) and of diagnostic relevance. Sample volume, elution volume, and processing time were also compared.

Conclusions

We observed differences in DNA yield as high as two orders of magnitude for some samples between the best and the worst DNA extraction kits and inhibition was observed occasionally. This indicates that DNA purification may be more relevant than expected when the amount of DNA in tissue is very low.
Literature
1.
go back to reference Al Dahouk S, Tomaso H, Nöckler K, Neubauer H, Frangoulidis D: Laboratory-based diagnosis of brucellosis - a review of the literature. Part I: techniques for direct detection and identification of Brucella spp. Clin Lab. 2003, 49: 487-505.PubMed Al Dahouk S, Tomaso H, Nöckler K, Neubauer H, Frangoulidis D: Laboratory-based diagnosis of brucellosis - a review of the literature. Part I: techniques for direct detection and identification of Brucella spp. Clin Lab. 2003, 49: 487-505.PubMed
2.
go back to reference Al Dahouk S, Nöckler K, Scholz HC, Pfeffer M, Neubauer H, Tomaso H: Evaluation of genus-specific and species-specific real-time PCR assays for the identification of Brucella spp. Clin Chem Lab Med. 2007, 45: 1464-1470. 10.1515/CCLM.2007.305.CrossRefPubMed Al Dahouk S, Nöckler K, Scholz HC, Pfeffer M, Neubauer H, Tomaso H: Evaluation of genus-specific and species-specific real-time PCR assays for the identification of Brucella spp. Clin Chem Lab Med. 2007, 45: 1464-1470. 10.1515/CCLM.2007.305.CrossRefPubMed
3.
go back to reference Bricker BJ: PCR as a diagnostic tool for brucellosis. Vet Microbiol. 2002, 90: 435-446. 10.1016/S0378-1135(02)00228-6.CrossRefPubMed Bricker BJ: PCR as a diagnostic tool for brucellosis. Vet Microbiol. 2002, 90: 435-446. 10.1016/S0378-1135(02)00228-6.CrossRefPubMed
4.
go back to reference Leal-Klevezas DS, Martínez-Vázquez IO, López-Merino A, Martínez-Soriano JP: Single-step PCR for detection of Brucella spp. from blood and milk of infected animals. J Clin Microbiol. 1995, 12: 3087-3090. Leal-Klevezas DS, Martínez-Vázquez IO, López-Merino A, Martínez-Soriano JP: Single-step PCR for detection of Brucella spp. from blood and milk of infected animals. J Clin Microbiol. 1995, 12: 3087-3090.
5.
go back to reference O'Leary S, Sheahan M, Sweeney T: Brucella abortus detection by PCR assay in blood, milk and lymph tissue of serologically positive cows. Res Vet Sci. 2006, 81: 170-176. 10.1016/j.rvsc.2005.12.001.CrossRefPubMed O'Leary S, Sheahan M, Sweeney T: Brucella abortus detection by PCR assay in blood, milk and lymph tissue of serologically positive cows. Res Vet Sci. 2006, 81: 170-176. 10.1016/j.rvsc.2005.12.001.CrossRefPubMed
6.
go back to reference Zerva L, Bourantas K, Mitka S, Kansouzidou A, Legakis NJ: Serum is the preferred clinical specimen for diagnosis of human brucellosis by PCR. J Clin Microbiol. 2001, 39: 1661-1664. 10.1128/JCM.39.4.1661-1664.2001.CrossRefPubMedPubMedCentral Zerva L, Bourantas K, Mitka S, Kansouzidou A, Legakis NJ: Serum is the preferred clinical specimen for diagnosis of human brucellosis by PCR. J Clin Microbiol. 2001, 39: 1661-1664. 10.1128/JCM.39.4.1661-1664.2001.CrossRefPubMedPubMedCentral
7.
go back to reference Queipo-Ortuño MI, Tena F, Colmenero JD, Morata P: Comparison of seven commercial DNA extraction kits for the recovery of Brucella DNA from spiked human serum samples using real-time PCR. Eur J Clin Microbiol Infect Dis. 2008, 27: 109-114. 10.1007/s10096-007-0409-y.CrossRefPubMed Queipo-Ortuño MI, Tena F, Colmenero JD, Morata P: Comparison of seven commercial DNA extraction kits for the recovery of Brucella DNA from spiked human serum samples using real-time PCR. Eur J Clin Microbiol Infect Dis. 2008, 27: 109-114. 10.1007/s10096-007-0409-y.CrossRefPubMed
8.
go back to reference Wernery U, Kinne J, Joseph M, Johnson B, Nagy P: Where do Brucella organisms hide in serologically positive lactating dromedaries?. Proc Int Camel Conf 16-17th. 2007, 68-70. February . Bikaner, Rajasthan, INDIA Wernery U, Kinne J, Joseph M, Johnson B, Nagy P: Where do Brucella organisms hide in serologically positive lactating dromedaries?. Proc Int Camel Conf 16-17th. 2007, 68-70. February . Bikaner, Rajasthan, INDIA
9.
go back to reference Bricker BJ, Halling SM: Differentiation of Brucella abortus bv. 1, 2, and 4, Brucella melitensis, Brucella ovis, and Brucella suis bv. 1 by PCR. J Clin Microbiol. 1994, 11: 2660-2666. Bricker BJ, Halling SM: Differentiation of Brucella abortus bv. 1, 2, and 4, Brucella melitensis, Brucella ovis, and Brucella suis bv. 1 by PCR. J Clin Microbiol. 1994, 11: 2660-2666.
10.
go back to reference Neubauer H, Meyer H, Prior J, Aleksic S, Hensel A, Splettstoesser W: A combination of different polymerase chain reaction (PCR) assays for the presumptive identification of Yersinia pestis. J Vet Med B. 2000, 47: 573-580. 10.1046/j.1439-0450.2000.00384.x.CrossRef Neubauer H, Meyer H, Prior J, Aleksic S, Hensel A, Splettstoesser W: A combination of different polymerase chain reaction (PCR) assays for the presumptive identification of Yersinia pestis. J Vet Med B. 2000, 47: 573-580. 10.1046/j.1439-0450.2000.00384.x.CrossRef
11.
go back to reference Tomaso H, Reisinger EC, Al Dahouk S, Frangoulidis D, Rakin A, Landt O, Neubauer H: Rapid detection of Yersinia pestis with multiplex real-time PCR assays using fluorescent hybridisation probes. FEMS Immunol Med Microbiol. 2003, 38: 117-26. 10.1016/S0928-8244(03)00184-6.CrossRefPubMed Tomaso H, Reisinger EC, Al Dahouk S, Frangoulidis D, Rakin A, Landt O, Neubauer H: Rapid detection of Yersinia pestis with multiplex real-time PCR assays using fluorescent hybridisation probes. FEMS Immunol Med Microbiol. 2003, 38: 117-26. 10.1016/S0928-8244(03)00184-6.CrossRefPubMed
12.
go back to reference Clinical and Laboratory Standards Institute: Evaluation of the linearity of quantitative measurement procedures: a statistical approach; approved guideline. CLSI document EP6-A. Wayne, PA: CLSI. 2003 Clinical and Laboratory Standards Institute: Evaluation of the linearity of quantitative measurement procedures: a statistical approach; approved guideline. CLSI document EP6-A. Wayne, PA: CLSI. 2003
Metadata
Title
Comparison of commercial DNA preparation kits for the detection of Brucellae in tissue using quantitative real-time PCR
Authors
Herbert Tomaso
Mireille Kattar
Meike Eickhoff
Ulrich Wernery
Sascha Al Dahouk
Eberhard Straube
Heinrich Neubauer
Holger C Scholz
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2010
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-10-100

Other articles of this Issue 1/2010

BMC Infectious Diseases 1/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine